NON-SMALL CELL LUNG CANCER STAGE IV
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IV trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets Hard-to-Treat cancers in first human study
Disease control Recruiting nowThis early-phase study tests a new radioactive drug, [177Lu]Lu-AKIR001, in 15 adults with advanced solid tumors (like thyroid, head and neck, cervical, vulvar, or lung cancer) that have a specific marker called CD44v6 and have stopped responding to standard treatments. The main g…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Virus therapy takes on lung cancer after standard treatment fails
Disease control Recruiting nowThis study tests a new approach for people with advanced non-small-cell lung cancer whose disease has worsened after initial chemotherapy and immunotherapy. Participants receive an experimental virus (Olvi-Vec) followed by chemotherapy plus an immunotherapy drug, or the standard …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Protein test could tailor lung cancer therapy for better survival
Disease control Recruiting nowThis study tests whether using a protein-based test to choose treatment can help people with advanced non-small cell lung cancer live longer without their cancer getting worse. About 56 adults with stage IIIC or IV lung cancer will be randomly assigned to either standard therapy …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Lung cancer survivors may breathe easier with pulmonary rehab, new study hopes to prove
Symptom relief Recruiting nowThis study tests whether a supervised exercise and breathing program (pulmonary rehabilitation) can improve shortness of breath and quality of life in people with advanced non-small cell lung cancer. Half of the 85 participants will receive 8 weeks of rehab, while the other half …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IV
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 03:55 UTC